메뉴 건너뛰기




Volumn 15, Issue 5, 2013, Pages

Chemoprevention of gastrointestinal neoplasia

Author keywords

Chemoprevention; Colorectal cancer; Esophageal Adenocarcinoma; Gastrointestinal neoplasia; GI oncology

Indexed keywords

ANTINEOPLASTIC AGENT; EFLORNITHINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

EID: 84884220419     PISSN: 15228037     EISSN: 1534312X     Source Type: Journal    
DOI: 10.1007/s11894-013-0320-x     Document Type: Article
Times cited : (7)

References (55)
  • 1
    • 0001869668 scopus 로고
    • Cancer chemopreventive agents. Drug development status and future prospects
    • Keloff, G.J., Boone, C.W. Cancer chemopreventive agents. Drug development status and future prospects. J. Cell. Biochem. 1994;20:1-103.
    • (1994) J. Cell. Biochem , vol.20 , pp. 1-103
    • Keloff, G.J.1    Boone, C.W.2
  • 3
    • 0025312728 scopus 로고
    • A genetic model for colorectal tumorigenesis
    • Fearon ER, Vogelstein BA. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759-67.
    • (1990) Cell , vol.61 , pp. 759-767
    • Fearon, E.R.1    Vogelstein, B.A.2
  • 6
    • 41349104451 scopus 로고    scopus 로고
    • Chemoprevention of colorectal neoplasia: The potential for personalized medicine
    • DOI 10.1053/j.gastro.2008.02.012, PII S0016508508002436
    • Arber N, Levin B. Chemoprevention of colorectal neoplasia: the potential for personalized medicine. Gastroenterology. 2008;134:1224-37. (Pubitemid 351451998)
    • (2008) Gastroenterology , vol.134 , Issue.4 , pp. 1224-1237
    • Arber, N.1    Levin, B.2
  • 7
    • 83955161674 scopus 로고    scopus 로고
    • Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: An analysis from the CAPP2 randomised controlled trial
    • Burn J, Gerdes AM, Macrae F, Mecklin JP, Moeslein G, Olschwang S, et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet. 2011;378(9809):2081-7.
    • (2011) Lancet , vol.378 , Issue.9809 , pp. 2081-2087
    • Burn, J.1    Gerdes, A.M.2    Macrae, F.3    Mecklin, J.P.4    Moeslein, G.5    Olschwang, S.6
  • 9
    • 33748180713 scopus 로고    scopus 로고
    • Celecoxib for prevention of colorectal adenomas
    • Arber N, Eagle CJ, Spicak J, et al. Celecoxib for prevention of colorectal adenomas. N Engl J Med. 2006;355:885-95.
    • (2006) N Engl J Med , vol.355 , pp. 885-895
    • Arber, N.1    Eagle, C.J.2    Spicak, J.3
  • 13
    • 78650215449 scopus 로고    scopus 로고
    • Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
    • Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet. 2010;376(9754):1741-50.
    • (2010) Lancet , vol.376 , Issue.9754 , pp. 1741-1750
    • Rothwell, P.M.1    Wilson, M.2    Elwin, C.E.3    Norrving, B.4    Algra, A.5    Warlow, C.P.6
  • 14
    • 84863412124 scopus 로고    scopus 로고
    • Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: Analysis of the time course of risks and benefits in 51 randomised controlled trials
    • Rothwell PM, Price JF, Fowkes FG, Zanchetti A, Roncaglioni MC, Tognoni G, et al. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet. 2012;379(9826):1602-12.
    • (2012) Lancet , vol.379 , Issue.9826 , pp. 1602-1612
    • Rothwell, P.M.1    Price, J.F.2    Fowkes, F.G.3    Zanchetti, A.4    Roncaglioni, M.C.5    Tognoni, G.6
  • 15
    • 84855556537 scopus 로고    scopus 로고
    • Aspirin in the chemoprevention of colorectal neoplasia: An overview
    • Chan AT, Arber N, Burn J, et al. Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prev Res (Phila). 2012;5:164-78.
    • (2012) Cancer Prev Res (Phila) , vol.5 , pp. 164-178
    • Chan, A.T.1    Arber, N.2    Burn, J.3
  • 19
    • 0036179267 scopus 로고    scopus 로고
    • Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA
    • DOI 10.1136/gut.50.3.368
    • El-Serag HB, Mason AC, Petersen N, Key CR. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut. 2002;50(3):368-72. (Pubitemid 34161053)
    • (2002) Gut , vol.50 , Issue.3 , pp. 368-372
    • El-Serag, H.B.1    Mason, A.C.2    Petersen, N.3    Key, C.R.4
  • 20
    • 73549083853 scopus 로고    scopus 로고
    • Clinical practice. Barrett's esophagus
    • Sharma P. Clinical practice. Barrett's esophagus. N Engl J Med. 2009;361:2548-56.
    • (2009) N Engl J Med , vol.361 , pp. 2548-2556
    • Sharma, P.1
  • 21
    • 0036179390 scopus 로고    scopus 로고
    • Surveillance and survival in Barrett's adenocarcinomas: A population-based study
    • Corley DA, Levin TR, Habel LA, Weiss NS, Buffler PA. Surveillance and survival in Barrett's adenocarcinomas: a populationbased study. Gastroenterology. 2002;122:633-40. (Pubitemid 34173814)
    • (2002) Gastroenterology , vol.122 , Issue.3 , pp. 633-640
    • Corley, D.A.1    Levin, T.R.2    Habel, L.A.3    Weiss, N.S.4    Buffler, P.A.5
  • 23
    • 79952288119 scopus 로고    scopus 로고
    • American gastroenterological association medical position statement on the management of Barrett's esophagus
    • Spechler SJ. American gastroenterological association medical position statement on the management of Barrett's esophagus. Gastroenterology. 2011;140:1084-91.
    • (2011) Gastroenterology , vol.140 , pp. 1084-1091
    • Spechler, S.J.1
  • 24
    • 84875365855 scopus 로고    scopus 로고
    • Proton pump inhibitors reduce the risk of neoplastic progression in patients with barrett's esophagus
    • Accepted for publication
    • Kastelein F, Spaander MCW, Steyerberg EW. Proton pump inhibitors reduce the risk of neoplastic progression in patients with barrett's esophagus. Clin Gastroenterol Hepatol. 2013 Accepted for publication.
    • (2013) Clin Gastroenterol Hepatol
    • Kastelein, F.1    Spaander, M.C.W.2    Steyerberg, E.W.3
  • 25
    • 81355160270 scopus 로고    scopus 로고
    • Systematic review: The use of proton pump inhibitors and increased susceptibility to enteric infection
    • Bavishi C, DuPont HL. Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Aliment Pharmacol Ther. 2011;34:1269-81.
    • (2011) Aliment Pharmacol Ther , vol.34 , pp. 1269-1281
    • Bavishi, C.1    Dupont, H.L.2
  • 26
    • 80455173556 scopus 로고    scopus 로고
    • Host and pathogen factors for Clostridium difficile infection and colonization
    • Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S, Turgeon N, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med. 2011;365(18):1693-703.
    • (2011) N Engl J Med , vol.365 , Issue.18 , pp. 1693-1703
    • Loo, V.G.1    Bourgault, A.M.2    Poirier, L.3    Lamothe, F.4    Michaud, S.5    Turgeon, N.6
  • 27
    • 77952837521 scopus 로고    scopus 로고
    • Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus
    • Nguyen DM, Richardson P, El-Serag HB. Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Gastroenterology. 2010;138:2260-6.
    • (2010) Gastroenterology , vol.138 , pp. 2260-2266
    • Nguyen, D.M.1    Richardson, P.2    El-Serag, H.B.3
  • 28
    • 0037219463 scopus 로고    scopus 로고
    • Protective association of aspirin/NSAIDs and esophageal cancer: A systematic review and meta-analysis
    • DOI 10.1053/gast.2003.50008
    • Corley DA, Kerlikowske K, Verma R, et al. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology. 2003;124:47-56. (Pubitemid 36055338)
    • (2003) Gastroenterology , vol.124 , Issue.1 , pp. 47-56
    • Corley, D.A.1    Kerlikowse, K.2    Verma, R.3    Buffler, P.4
  • 29
    • 28044459843 scopus 로고    scopus 로고
    • Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: A prospective study
    • DOI 10.1016/S1470-2045(05)70431-9, PII S1470204505704319
    • Vaughan TL, Dong LM, Blount PL, et al. Non-steroidal antiinflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study. Lancet Oncol. 2005;6:945-52. (Pubitemid 41685227)
    • (2005) Lancet Oncology , vol.6 , Issue.12 , pp. 945-952
    • Vaughan, T.L.1    Dong, L.M.2    Blount, P.L.3    Ayub, K.4    Odze, R.D.5    Sanchez, C.A.6    Rabinovitch, P.S.7    Reid, B.J.8
  • 30
    • 33646436171 scopus 로고    scopus 로고
    • Nonsteroidal antiinflammatory drugs and the esophageal inflammationmetaplasiaadenocarcinoma sequence
    • Anderson LA, Johnston BT, Watson RG, et al. Nonsteroidal antiinflammatory drugs and the esophageal inflammationmetaplasiaadenocarcinoma sequence. Cancer Res. 2006;66:4975-82.
    • (2006) Cancer Res , vol.66 , pp. 4975-4982
    • Anderson, L.A.1    Johnston, B.T.2    Watson, R.G.3
  • 31
    • 33646519470 scopus 로고    scopus 로고
    • Regular aspirin use and esophageal cancer risk
    • Jayaprakash V, Menezes RJ, Javle MM, et al. Regular aspirin use and esophageal cancer risk. Int J Cancer. 2006;119:202-7.
    • (2006) Int J Cancer , vol.119 , pp. 202-207
    • Jayaprakash, V.1    Menezes, R.J.2    Javle, M.M.3
  • 33
    • 0029092874 scopus 로고
    • Aspirin and reduced risk of esophageal carcinoma
    • Ellen M, Funkhouser PH, Gerald B, Sharp PH. Aspirin and reduced risk of esophageal carcinoma. Cancer. 1995;76(7):1116-9.
    • (1995) Cancer , vol.76 , Issue.7 , pp. 1116-1119
    • Ellen, M.1    Funkhouser, P.H.2    Gerald, B.3    Sharp, P.H.4
  • 34
    • 84866682144 scopus 로고    scopus 로고
    • A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E2 in patients with Barrett's esophagus
    • Falk GW, Buttar NS, Foster NR, Ziegler KL, Demars CJ, Romero Y, et al. A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E2 in patients with Barrett's esophagus. Gastroenterology. 2012;143:917-26.
    • (2012) Gastroenterology , vol.143 , pp. 917-926
    • Falk, G.W.1    Buttar, N.S.2    Foster, N.R.3    Ziegler, K.L.4    Demars, C.J.5    Romero, Y.6
  • 36
    • 81855167480 scopus 로고    scopus 로고
    • Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus
    • Kastelein F, Spaander MC, Biermann K, Steyerberg EW, Kuipers EJ, Bruno MJ, et al. Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus. Gastroenterology. 2011;141(6):2000-8.
    • (2011) Gastroenterology , vol.141 , Issue.6 , pp. 2000-2008
    • Kastelein, F.1    Spaander, M.C.2    Biermann, K.3    Steyerberg, E.W.4    Kuipers, E.J.5    Bruno, M.J.6
  • 38
    • 33750627697 scopus 로고    scopus 로고
    • Statins and cancer risk: A literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials
    • DOI 10.1200/JCO.2006.06.3560
    • Bonovas S, Filioussi K, Tsavaris N, Sitaras NM. Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials. J Clin Oncol. 2006;24:4808-17. (Pubitemid 46655612)
    • (2006) Journal of Clinical Oncology , vol.24 , Issue.30 , pp. 4808-4817
    • Bonovas, S.1    Filioussi, K.2    Tsavaris, N.3    Sitaras, N.M.4
  • 39
    • 54849131100 scopus 로고    scopus 로고
    • Statins and cancer: A systematic review and metaanalysis
    • Kuoppala J, Lamminpaa A, Pukkala E. Statins and cancer: a systematic review and metaanalysis. Eur J Cancer. 2008;44:2122-32.
    • (2008) Eur J Cancer , vol.44 , pp. 2122-2132
    • Kuoppala, J.1    Lamminpaa, A.2    Pukkala, E.3
  • 40
    • 84881491358 scopus 로고    scopus 로고
    • Statins are associated with a reduced risk of hepatocellular cancer: A systematic review and meta-analysis
    • Singh S, Singh PP, Singh AG, Murad MH, Sanchez W. Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis. Gastroenterology. 2013;144:323-332
    • (2013) Gastroenterology , vol.144 , pp. 323-332
    • Singh, S.1    Singh, P.P.2    Singh, A.G.3    Murad, M.H.4    Sanchez, W.5
  • 42
    • 84864031678 scopus 로고    scopus 로고
    • Regular statin and aspirin use in patients with Barrett's oesophagus is associated with a reduced incidence of oesophageal adenocarcinoma
    • Beales IL, Vardi I, Dearman L. Regular statin and aspirin use in patients with Barrett's oesophagus is associated with a reduced incidence of oesophageal adenocarcinoma. Eur J Gastroenterol Hepatol 2012;24(8):917-23.
    • (2012) Eur J Gastroenterol Hepatol , vol.24 , Issue.8 , pp. 917-923
    • Beales, I.L.1    Vardi, I.2    Dearman, L.3
  • 44
    • 80053367221 scopus 로고    scopus 로고
    • Exposure to statins and risk of common cancers: A series of nested case-control studies
    • Vinogradova Y, Coupland C, Hippisley-Cox J. Exposure to statins and risk of common cancers: a series of nested case-control studies. BMC Cancer. 2011;11:409.
    • (2011) BMC Cancer , vol.11 , pp. 409
    • Vinogradova, Y.1    Coupland, C.2    Hippisley-Cox, J.3
  • 45
    • 84878135553 scopus 로고    scopus 로고
    • Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: A systematic review and metaanalysis
    • doi:10.1016/ j.cgh.2012.12.036
    • Singh S, Singh AG, Singh PP, Murad MH, Iyer PG. Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and metaanalysis. Clin Gastroenterol Hepatol. 2013. doi:10.1016/ j.cgh.2012.12.036.
    • (2013) Clin Gastroenterol Hepatol.
    • Singh, S.1    Singh, A.G.2    Singh, P.P.3    Murad, M.H.4    Iyer, P.G.5
  • 46
    • 4944242891 scopus 로고    scopus 로고
    • Polyamines and cancer: Old molecules, new understanding
    • DOI 10.1038/nrc1454
    • Gerner EW, Meyskens Jr FL. Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer. 2004;4:781-92. (Pubitemid 39331150)
    • (2004) Nature Reviews Cancer , vol.4 , Issue.10 , pp. 781-792
    • Gerner, E.W.1    Meyskens Jr., F.L.2
  • 47
    • 0345535621 scopus 로고    scopus 로고
    • Development of difluoromethylornithine (DFMO) as a chemoprevention agent
    • Meyskens Jr FL, Gerner EW. Development of difluoromethylornithine (DFMO) as a chemoprevention agent. Clin Cancer Res. 1999;5:945-51. (Pubitemid 29233206)
    • (1999) Clinical Cancer Research , vol.5 , Issue.5 , pp. 945-951
    • Meyskens Jr., F.L.1    Gerner, E.W.2
  • 48
    • 0014323475 scopus 로고
    • Amine synthesis in rapidly growing tissues: Ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors
    • Russell D, Snyder SH. Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver, chick embryo, and various tumors. Proc Natl Acad Sci USA. 1968;60:1420-7.
    • (1968) Proc Natl Acad Sci USA , vol.60 , pp. 1420-1427
    • Russell, D.1    Snyder, S.H.2
  • 49
    • 0023925010 scopus 로고
    • Ornithine decarboxylase and polyamine levels in columnar upper gastrointestinal mucosae in patients with Barrett's esophagus
    • Garewal HS, Gerner EW, Sampliner RE, Roe D. Ornithine decarboxylase and polyamine levels in columnar upper gastrointestinal mucosae in patients with Barrett's esophagus. Cancer Res. 1988;48(11):3288-91.
    • (1988) Cancer Res , vol.48 , Issue.11 , pp. 3288-3291
    • Garewal, H.S.1    Gerner, E.W.2    Sampliner, R.E.3    Roe, D.4
  • 50
    • 0032403096 scopus 로고    scopus 로고
    • α-Difluoromethylornithine inhibits N-nitrosomethylbenzylamine- induced esophageal carcinogenesis in zinc-deficient rats: Effects on esophageal cell proliferation and apoptosis
    • Fong LY, Pegg AE, Magee PN. Alpha-difluoromethylornithine inhibits N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in zinc-deficient rats: effects on esophageal cell proliferation and apoptosis. Cancer Res. 1998;58:5380-8. (Pubitemid 28551120)
    • (1998) Cancer Research , vol.58 , Issue.23 , pp. 5380-5388
    • Fong, L.Y.Y.1    Pegg, A.E.2    Magee, P.N.3
  • 51
    • 0028658301 scopus 로고
    • Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: Methods and results from the NCI Chemoprevention Drug Development Program
    • Steele VE, Moon RC, Lubet RA, Grubbs CJ, Reddy BS, Wargovich M, et al. Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI Chemoprevention Drug Development Program. J Cell Biochem Suppl. 1994;20:32-54.
    • (1994) J Cell Biochem Suppl , vol.20 , pp. 32-54
    • Steele, V.E.1    Moon, R.C.2    Lubet, R.A.3    Grubbs, C.J.4    Reddy, B.S.5    Wargovich, M.6
  • 52
    • 84870662091 scopus 로고    scopus 로고
    • A phase III skin cancer chemoprevention study of DFMO: Long-term follow-up of skin cancer events and toxicity
    • Kreul SM, Havighurst T, Kim K, Mendonça EA, Wood GS, Snow S, et al. A phase III skin cancer chemoprevention study of DFMO: long-term follow-up of skin cancer events and toxicity. Cancer Prev Res (Phila). 2012;5(12):1368-74.
    • (2012) Cancer Prev Res (Phila) , vol.5 , Issue.12 , pp. 1368-1374
    • Kreul, S.M.1    Havighurst, T.2    Kim, K.3    Mendonça, E.A.4    Wood, G.S.5    Snow, S.6
  • 53
    • 0028358206 scopus 로고
    • Gastrointestinal tissue polyamine contents of patients with Barrett's esophagus treated with α-difluoromethylornithine
    • Gerner EW, Garewal HS, Emerson SS, Sampliner RE. Gastrointestinal tissue polyamine contents of patients with Barrett's esophagus treated with alpha-difluoromethylornithine. Cancer Epidemiol Biomarkers Prev. 1994;3(4):325-30. (Pubitemid 24181577)
    • (1994) Cancer Epidemiology Biomarkers and Prevention , vol.3 , Issue.4 , pp. 325-330
    • Gerner, E.W.1    Garewal, H.S.2    Emerson, S.S.3    Sampliner, R.E.4
  • 54
    • 18044404506 scopus 로고    scopus 로고
    • Upregulation of ornithine decarboxylase mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma
    • discussion 82
    • Brabender J, Lord RV, Danenberg KD, Metzger R, Schneider PM, Uetake H, et al. Upregulation of ornithine decarboxylase mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma. J Gastrointest Surg. 2001;5:174-81. discussion 82.
    • (2001) J Gastrointest Surg , vol.5 , pp. 174-181
    • Brabender, J.1    Lord, R.V.2    Danenberg, K.D.3    Metzger, R.4    Schneider, P.M.5    Uetake, H.6
  • 55
    • 79957810567 scopus 로고    scopus 로고
    • Evaluation of difluoromethylornithine for the chemoprevention of Barrett's esophagus and mucosal dysplasia
    • Sinicrope FA, Broaddus R, Joshi N, Gerner E, Half E, Kirsch I, et al. Evaluation of difluoromethylornithine for the chemoprevention of Barrett's esophagus and mucosal dysplasia. Cancer Prev Res (Phila). 2011;4(6):829-39.
    • (2011) Cancer Prev Res (Phila) , vol.4 , Issue.6 , pp. 829-839
    • Sinicrope, F.A.1    Broaddus, R.2    Joshi, N.3    Gerner, E.4    Half, E.5    Kirsch, I.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.